IMMX: Immix Biopharma, Inc. Stock

by  •  • Comments Off on IMMX: Immix Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 58.22
Enterprise Value ($M) 42.30
Book Value ($M) 9.59
Book Value / Share 0.35
Price / Book 6.07
NCAV ($M) 6.48
NCAV / Share 0.23
Price / NCAV 8.98

Profitability (mra)
Return on Invested Capital (ROIC) -1.96
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.76

Liquidity (mrq)
Quick Ratio 1.80
Current Ratio 1.80

Balance Sheet (mrq) ($M)
Current Assets 16.78
Assets 19.89
Liabilities 10.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -22.67
Net Income -21.61
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -14.60
Cash from Investing -1.18
Cash from Financing 15.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-29 13G/A Hirschman Orin 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 17,963 47,064 38.17
2025-05-08 15,303 55,834 27.41
2025-05-07 5,035 25,137 20.03
2025-05-06 8,325 41,512 20.05
2025-05-05 9,621 42,840 22.46

(click for more detail)

Similar Companies
ICCC – ImmuCell Corporation IKT – Inhibikase Therapeutics, Inc.
IMCC – IM Cannabis Corp. IMNM – Immunome, Inc.
IMNN – Imunon, Inc.


Financial data and stock pages provided by
Fintel.io